FAVA, Carmen
FAVA, Carmen
SCIENZE CLINICHE E BIOLOGICHE
"Real-life" Frontline Dasatinib Treatment in Unselected Elderly Patients with Chronic Myeloid Leukemia
2014-01-01 Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Breccia, M; Vigneri, Pg; Trawinska, Mm; Guarini, A; Alimena, G
"REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
2015-01-01 Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G
A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia
2019-01-01 Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
2015-01-01 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G
A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.
2006-01-01 Emilia Giugliano; Dario Ferrero; Carmen Fava; Chiara Dellacasa; Giovanna Mattioli; Patrizia Scaravaglio; Enrico Gottardi; Stefano Ulisciani; Filomena Daraio; Giuseppe Saglio; Giovanna Rege.
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib.
2012-01-01 Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno.
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience.
2012-01-01 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A Retrospective Real-Life Report on Newly Diagnosed Adult Ph plus Acute Lymphoblastic Leukemia (Ph plus ALL) Patients Treated in Italy - The CAMPUS-ALL Experience
2020-01-01 Dragani, M; Agrippino, R; Cambrin, GR; Mancini, V; Annunziata, M; Lunghi, M; Ciccone, M; Malato, A; Chiusolo, P; Fava, C; Berchialla, P; Foa, R; Chiaretti, S
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease
2017-01-01 Daraio, F; Giugliano, E; Fava, C; Lorenzatti, R; Varotto, M; Barberio, D; Bernardi, S; Izzo, B; Errichiello, S; Bochicchio, MT; Venturi, C; Albano, F; Saglio, G; Pane, F; Martinelli, G; Specchia, G; Russo, D; Gottardi, EM
Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis
2017-01-01 Gugliotta, G; Castagnetti, F; Breccia, M; D'adda, M; Stagno, F; Levato, L; Carella, AM; Martino, B; Tiribelli, M; Fava, C; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, AR; Luciano, L; Soverini, S; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G
CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP
2015-01-01 Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G
CHARLSON COMORBIDITIES INDEX (CCI) MAY PREDICT COMPLIANCE AND DEVELOPMENT OF PLEURAL EFFUSIONS IN ELDERLY CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT PATIENTS TREATED WITH DASATINIB
2010-01-01 Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F;Ulisciani S;Cavazzini F;Annunziata M;Sorà F;Russo Rossi A; Pregno P; Porrini R; Abruzzese E; Giai V; Musto P;Tiribelli M; Binotto G; Occhini U; Vallone R; Martino B; Capodanno I; Spina F;Pane F; Santini V; Rosti G; Fava C; Alimena G
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET
2016-01-01 Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S
Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML)
2008-01-01 Santos FPS ; Kantarjian H; Fava C; O’Brien S; Garcia-Manero G; Kornblau S; Ravandi F; Wierda W; Cortes J
Clinical significance of early molecular response in chronic myeloid leukemia patients treated frontline with imatinib mesylate.
2013-01-01 F Castagnetti; G Gugliotta; M Breccia; F Albano; E Abruzzese; L Levato; F Cavazzini; A Iurlo; F Stagno; D Ferrero; F Porretto; B Martino; S Rupoli; T Intermesoli; C Fava; I Pierri; F Palandri; C Venturi; S Soverini; S Luatti; G Alimena; F Pane; G Martinelli; G Saglio; M Cavo; M Baccarani; G Rosti.
Clinical Use of Imatinib Plasma Levels in Patients with Chronic Myeloid Leukemia (CML)
2008-01-01 Ault P; Kantarjian HM; Bryan J; Prescot H; Alvarado Y; Fava C; Cortes J
Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
2009-01-01 Fava, C; Cambrin, GR; Ferrero, D; Ulisciani, S; Serra, A
Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia
2015-01-01 Galimberti, S; Galeotti, L; Ceccherini, F; Domingo, D; Laurino, M; Polillo, M; Di Paolo, A; Barate, C; Fava, C; D'Avolio, A; Fontanelli, G; Danesi, R; Cornolti, F; Guerrini, F; Ciabatti, E; Saglio, G; Petrini, M
Comorbidities influence compliance and developement of pleural effusions in elderly chronic myeloid leukemia (CML) patients treated with dasatinib.
2009-01-01 Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Rege-Cambrin G.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Russo Rossi A.; Specchia G.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G.
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4
2015-01-01 Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Real-life" Frontline Dasatinib Treatment in Unselected Elderly Patients with Chronic Myeloid Leukemia | 2014 | Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Breccia, M; Vigneri, Pg; Trawinska, Mm; Guarini, A; Alimena, G | |
| "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 2015 | Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G | |
| A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia | 2019 | Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco | |
| A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS | 2015 | Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G | |
| A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML. | 2006 | Emilia Giugliano; Dario Ferrero; Carmen Fava; Chiara Dellacasa; Giovanna Mattioli; Patrizia Scaravaglio; Enrico Gottardi; Stefano Ulisciani; Filomena Daraio; Giuseppe Saglio; Giovanna Rege. | |
| A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. | 2012 | Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno. | |
| A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. | 2012 | Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P. | |
| A Retrospective Real-Life Report on Newly Diagnosed Adult Ph plus Acute Lymphoblastic Leukemia (Ph plus ALL) Patients Treated in Italy - The CAMPUS-ALL Experience | 2020 | Dragani, M; Agrippino, R; Cambrin, GR; Mancini, V; Annunziata, M; Lunghi, M; Ciccone, M; Malato, A; Chiusolo, P; Fava, C; Berchialla, P; Foa, R; Chiaretti, S | |
| An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease | 2017 | Daraio, F; Giugliano, E; Fava, C; Lorenzatti, R; Varotto, M; Barberio, D; Bernardi, S; Izzo, B; Errichiello, S; Bochicchio, MT; Venturi, C; Albano, F; Saglio, G; Pane, F; Martinelli, G; Specchia, G; Russo, D; Gottardi, EM | |
| Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis | 2017 | Gugliotta, G; Castagnetti, F; Breccia, M; D'adda, M; Stagno, F; Levato, L; Carella, AM; Martino, B; Tiribelli, M; Fava, C; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, AR; Luciano, L; Soverini, S; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G | |
| CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP | 2015 | Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G | |
| CHARLSON COMORBIDITIES INDEX (CCI) MAY PREDICT COMPLIANCE AND DEVELOPMENT OF PLEURAL EFFUSIONS IN ELDERLY CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT PATIENTS TREATED WITH DASATINIB | 2010 | Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F;Ulisciani S;Cavazzini F;Annunziata M;Sorà F;Russo Rossi A; Pregno P; Porrini R; Abruzzese E; Giai V; Musto P;Tiribelli M; Binotto G; Occhini U; Vallone R; Martino B; Capodanno I; Spina F;Pane F; Santini V; Rosti G; Fava C; Alimena G | |
| CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET | 2016 | Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S | |
| Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML) | 2008 | Santos FPS ; Kantarjian H; Fava C; O’Brien S; Garcia-Manero G; Kornblau S; Ravandi F; Wierda W; Cortes J | |
| Clinical significance of early molecular response in chronic myeloid leukemia patients treated frontline with imatinib mesylate. | 2013 | F Castagnetti; G Gugliotta; M Breccia; F Albano; E Abruzzese; L Levato; F Cavazzini; A Iurlo; F Stagno; D Ferrero; F Porretto; B Martino; S Rupoli; T Intermesoli; C Fava; I Pierri; F Palandri; C Venturi; S Soverini; S Luatti; G Alimena; F Pane; G Martinelli; G Saglio; M Cavo; M Baccarani; G Rosti. | |
| Clinical Use of Imatinib Plasma Levels in Patients with Chronic Myeloid Leukemia (CML) | 2008 | Ault P; Kantarjian HM; Bryan J; Prescot H; Alvarado Y; Fava C; Cortes J | |
| Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia | 2009 | Fava, C; Cambrin, GR; Ferrero, D; Ulisciani, S; Serra, A | |
| Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia | 2015 | Galimberti, S; Galeotti, L; Ceccherini, F; Domingo, D; Laurino, M; Polillo, M; Di Paolo, A; Barate, C; Fava, C; D'Avolio, A; Fontanelli, G; Danesi, R; Cornolti, F; Guerrini, F; Ciabatti, E; Saglio, G; Petrini, M | |
| Comorbidities influence compliance and developement of pleural effusions in elderly chronic myeloid leukemia (CML) patients treated with dasatinib. | 2009 | Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Rege-Cambrin G.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Russo Rossi A.; Specchia G.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G. | |
| COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 | 2015 | Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G |